Risk of hypoglycaemia in people aged >/=65 years receiving linagliptin: pooled data from 1489 individuals with type 2 diabetes mellitus.
AIMS: To investigate the risk of hypoglycaemia in people aged >/=65 years with type 2 diabetes mellitus (T2DM) treated with linagliptin, in the largest pooled analysis performed to date. MATERIALS AND METHODS: One thousand four hundred and eighty-nine pat.....